SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
X	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* HAUSER HERMANN (Last) (First) (Middle) C/O SOLEXA, INC. 25861 INDUSTRIAL BLVD. (Street) HAYWARD CA 94545 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol Solexa, Inc. [ SLXA ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner Officer (give title below) Other (specify below)
	3. Date of Earliest Transaction (Month/Day/Year) 01/26/2007
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/26/2007		D		2,089,849	D	(1)	0	I	By Amadeus II A LP
Common Stock	01/26/2007		D		1,393,234	D	(2)	0	I	By Amadeus II B LP
Common Stock	01/26/2007		D		975,264	D	(3)	0	I	By Amadeus II C LP
Common Stock	01/26/2007		D		46,442	D	(4)	0	I	By Amadeus II D GmbH and Co KG
Common Stock	01/26/2007		D		139,322	D	(5)	0	I	By Amadeus II Affiliates LP

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$9.06	01/26/2007		D			10,000	(6)	10/03/2016	Common Stock	10,000	$0.00	0	D
Stock Option (Right to Buy)	$6.2	01/26/2007		D			20,000	(7)	10/21/2015	Common Stock	20,000	$0.00	0	D
Warrant (Right to Buy)	$7.5	01/26/2007		D			60,577	(8)	01/19/2011	Common Stock	60,577	$0.00	0	I	By Amadeus II LP
Warrant (Right to Buy)	$7.5	01/26/2007		D			40,385	(9)	01/19/2011	Common Stock	40,385	$0.00	0	I	By Amadeus II B LP
Warrant (Right to Buy)	$7.5	01/26/2007		D			28,269	(10)	01/19/2011	Common Stock	28,269	$0.00	0	I	By Amadeus II C LP
Warrant (Right to Buy)	$7.5	01/26/2007		D			1,346	(11)	01/19/2011	Common Stock	1,346	$0.00	0	I	By Amadeus II D GmbH and Co KG
Warrant (Right to Buy)	$7.5	01/26/2007		D			4,038	(12)	01/19/2011	Common Stock	4,038	$0.00	0	I	By Amadeus II Affiliates LP

Explanation of Responses:

1. These shares were surrendered pursuant to a merger agreement between Solexa, Inc. and Illumina, Inc. in exchange for 718,908 shares of Illumina, Inc. common stock.

2. These shares were surrendered pursuant to a merger agreement between Solexa, Inc. and Illumina, Inc. in exchange for 479,272 shares of Illumina, Inc. common stock.

3. These shares were surrendered pursuant to a merger agreement between Solexa, Inc. and Illumina, Inc. in exchange for 335,490 shares of Illumina, Inc. common stock.

4. These shares were surrendered pursuant to a merger agreement between Solexa, Inc. and Illumina, Inc. in exchange for 15,976 shares of Illumina, Inc. common stock.

5. These shares were surrendered pursuant to a merger agreement between Solexa, Inc. and Illumina, Inc. in exchange for 47,926 shares of Illumina, Inc. common stock.

6. This option, which provided for vesting monthly and ratably over the 12 month period beginning on October 21, 2005, was assumed by Illumina, Inc. in connection with the merger with Solexa, Inc. and replaced with an option to purchase 6,880 shares at an exercise price of $18.02 per share.

7. This option, which provided for vesting monthly and ratably over the 12 month period beginning on October 4, 2006, was assumed by Illumina, Inc. in connection with the merger with Solexa, Inc. and replaced with an option to purchase 3,440 shares at an exercise price of $26.34 per share.

8. This warrant, which was exercisable 180 days from January 19, 2006, was assumed by Illumina, Inc. in connection with the merger with Solexa, Inc. and replaced with a warrant to purchase 20,838 shares at an exercise price of $21.80 per share.

9. This warrant, which was exercisable 180 days from January 19, 2006, was assumed by Illumina, Inc. in connection with the merger with Solexa, Inc. and replaced with a warrant to purchase 13,892 shares at an exercise price of $21.80 per share.

10. This warrant, which was exercisable 180 days from January 19, 2006, was assumed by Illumina, Inc. in connection with the merger with Solexa, Inc. and replaced with a warrant to purchase 9,724 shares at an exercise price of $21.80 per share.

11. This warrant, which was exercisable 180 days from January 19, 2006, was assumed by Illumina, Inc. in connection with the merger with Solexa, Inc. and replaced with a warrant to purchase 463 shares at an exercise price of $21.80 per share.

12. This warrant, which was exercisable 180 days from January 19, 2006, was assumed by Illumina, Inc. in connection with the merger with Solexa, Inc. and replaced with a warrant to purchase 1,389 shares at an exercise price of $21.80 per share.

	/s/ Hermann Hauser, by Kathy San Roman, attorney-in-fact	01/29/2007
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.